EUVIMEDEUVIMED entdecken
Kohortenstudie

Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study

Lawrence Kogan, Matthew J Townsend, Dhanya Raj, Alexander N Levy, Anita Giobbie-Hurder, Shilpa Grover iD

Inflammatory Bowel Diseases · 2024

DOI: 10.1093/ibd/izad121 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Inflammatory Bowel Diseases, 2024. Verfasst von Lawrence Kogan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Digestive Diseases, Yale School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Biomarkers, Inflammatory Bowel Diseases, Enterocolitis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lay Summary In the emerging field of immune checkpoint inhibitor enterocolitis, biomarkers to predict disease course are lacking. Select genetic polymorphisms (ATG16L1T300A) and serum amyloid A warrant further study as potential biomarkers associated with severe ICI enterocolitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsBiomarkersInflammatory Bowel DiseasesEnterocolitisHumansRetrospective StudiesPrognosisMaleFemaleMiddle AgedAdultAged

Stichwörter der Autor:innen

biologicbiomarkercolitisimmune checkpoint inhibitorimmune-related adverse event

Substanzen

Immune Checkpoint InhibitorsBiomarkers

Autor:innen und Institutionen

  • Division of Digestive Diseases, Yale School of Medicine, New Haven, CT, USA.
  • Department of Medicine, Duke University Medical Center, Durham, NC, USA.
  • Division of Gastroenterology, Hepatology, and Endoscopy, Brigham & Women's Hospital, Boston, MA, USA.
  • Division of Gastroenterology, Tufts Medical Center, Boston, MA, USA.
  • Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Shilpa Grover

Zitieren

APA

Kogan, L., Townsend, M. J., Raj, D., Levy, A. N., Giobbie-Hurder, A., & Grover, S. (2024). Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izad121

Vancouver

Kogan L, Townsend MJ, Raj D, Levy AN, Giobbie-Hurder A, Grover S. Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study. Inflammatory Bowel Diseases. 2024. doi:10.1093/ibd/izad121

BibTeX
@article{Kogan2024,
  author = {Kogan, Lawrence and Townsend, Matthew J and Raj, Dhanya and Levy, Alexander N and Giobbie-Hurder, Anita and Grover, Shilpa},
  title = {Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study},
  journal = {Inflammatory Bowel Diseases},
  year = {2024},
  doi = {10.1093/ibd/izad121}
}
Kostenlos starten →